Search research articles
Contact Us
Filters
Showing results (51-60 of 134) with videos related to
Page
of 14
Sort By:
International Journal of Dermatology
|
July 25, 2013
Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions
Jonathan L Curry, Carlos A Torres-Cabala, Kevin B Kim, et al.
BMC Cancer
|
April 18, 2015
Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance
Jennifer Wheler, Roman Yelensky, Gerald Falchook, et al.
Cancers
|
August 10, 2024
Preoperative and Intraoperative Identification of Sentinel Lymph Nodes in Melanoma Surgery
Stanley P Leong, Mehdi Nosrati, Max C Wu, et al.
Cancer Investigation
|
May 15, 2009
A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma
Agop Y Bedikian, Nicholas E Papadopoulos, Kevin B Kim, et al.
Annals of Surgical Oncology
|
December 4, 2004
A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma
Matthew T Ballo, Gunar K Zagars, Jeffrey E Gershenwald, et al.
Molecular Cancer Therapeutics
|
December 7, 2002
Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cells
Kevin B Kim, Reuben Lotan, Ping Yue, et al.
Melanoma Research
|
November 25, 2010
Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?
Agop Y Bedikian, Marcella M Johnson, Carla L Warneke, et al.
The Journal of Dermatology
|
March 13, 2014
Case of vemurafenib-induced Sweet's syndrome
Jeffrey T Yorio, Steven R Mays, Ana M Ciurea, et al.
The Lancet. Oncology
|
June 6, 2013
Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study
Caroline Robert, Reinhard Dummer, Ralf Gutzmer, et al.
Journal of Clinical Pharmacology
|
October 28, 2010
Pharmacokinetics and safety of Marqibo (vincristine sulfate liposomes injection) in cancer patients with impaired liver function
Agop Y Bedikian, Jeffrey A Silverman, Nicholas E Papadopoulos, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 134) with videos related to
Sort By:
Page
of 14
International Journal of Dermatology
|
July 25, 2013
Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions
Jonathan L Curry, Carlos A Torres-Cabala, Kevin B Kim, et al.
BMC Cancer
|
April 18, 2015
Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance
Jennifer Wheler, Roman Yelensky, Gerald Falchook, et al.
Cancers
|
August 10, 2024
Preoperative and Intraoperative Identification of Sentinel Lymph Nodes in Melanoma Surgery
Stanley P Leong, Mehdi Nosrati, Max C Wu, et al.
Cancer Investigation
|
May 15, 2009
A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma
Agop Y Bedikian, Nicholas E Papadopoulos, Kevin B Kim, et al.
Annals of Surgical Oncology
|
December 4, 2004
A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma
Matthew T Ballo, Gunar K Zagars, Jeffrey E Gershenwald, et al.
Molecular Cancer Therapeutics
|
December 7, 2002
Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cells
Kevin B Kim, Reuben Lotan, Ping Yue, et al.
Melanoma Research
|
November 25, 2010
Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?
Agop Y Bedikian, Marcella M Johnson, Carla L Warneke, et al.
The Journal of Dermatology
|
March 13, 2014
Case of vemurafenib-induced Sweet's syndrome
Jeffrey T Yorio, Steven R Mays, Ana M Ciurea, et al.
The Lancet. Oncology
|
June 6, 2013
Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study
Caroline Robert, Reinhard Dummer, Ralf Gutzmer, et al.
Journal of Clinical Pharmacology
|
October 28, 2010
Pharmacokinetics and safety of Marqibo (vincristine sulfate liposomes injection) in cancer patients with impaired liver function
Agop Y Bedikian, Jeffrey A Silverman, Nicholas E Papadopoulos, et al.
Page
of 14